Literature DB >> 18490691

It's time to overcome clinical inertia.

Lawrence S Phillips, Jennifer G Twombly.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18490691      PMCID： PMC3685435          DOI： 10.7326/0003-4819-148-10-200805200-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  20 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures.

Authors:  E A Kerr; S L Krein; S Vijan; T P Hofer; R A Hayward
Journal:  Am J Manag Care       Date:  2001-11       Impact factor: 2.229

3.  Impact of high-normal blood pressure on the risk of cardiovascular disease.

Authors:  R S Vasan; M G Larson; E P Leip; J C Evans; C J O'Donnell; W B Kannel; D Levy
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

4.  Variation in diabetes care among states: do patient characteristics matter?

Authors:  David R Arday; Barbara B Fleming; Dana K Keller; Peter W Pendergrass; Robert J Vaughn; James M Turpin; David A Nicewander
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

5.  Physician-related barriers to the effective management of uncontrolled hypertension.

Authors:  Susan A Oliveria; Pablo Lapuerta; Bruce D McCarthy; Gilbert J L'Italien; Dan R Berlowitz; Steven M Asch
Journal:  Arch Intern Med       Date:  2002-02-25

6.  Outcomes of audit-enhanced monitoring of patients with type 2 diabetes.

Authors:  Wim J C de Grauw; Willem H E M van Gerwen; Eloy H van de Lisdonk; Henk J M van den Hoogen; Wil J H M van den Bosch; Chris van Weel
Journal:  J Fam Pract       Date:  2002-05       Impact factor: 0.493

7.  Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

8.  Hypertension management in patients with diabetes: the need for more aggressive therapy.

Authors:  Dan R Berlowitz; Arlene S Ash; Elaine C Hickey; Mark Glickman; Robert Friedman; Boris Kader
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

9.  Effect of unrelated comorbid conditions on hypertension management.

Authors:  Barbara J Turner; Christopher S Hollenbeak; Mark Weiner; Thomas Ten Have; Simon S K Tang
Journal:  Ann Intern Med       Date:  2008-04-15       Impact factor: 25.391

10.  Little time for diabetes management in the primary care setting.

Authors:  Catherine S Barnes; David C Ziemer; Chris D Miller; Joyce P Doyle; Clyde Watkins; Curtiss B Cook; Dan L Gallina; Imad el-Kebbi; William T Branch; Lawrence S Phillips
Journal:  Diabetes Educ       Date:  2004 Jan-Feb       Impact factor: 2.140
View more
  33 in total

1.  Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial.

Authors:  Paul L Hebert; Jane E Sisk; Leah Tuzzio; Jodi M Casabianca; Velvie A Pogue; Jason J Wang; Yingchun Chen; Christine Cowles; Mary Ann McLaughlin
Journal:  J Gen Intern Med       Date:  2011-12-06       Impact factor: 5.128

2.  A STITCH saves time and lowers blood pressure.

Authors:  Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

3.  Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.

Authors:  Leslie R Harrold; J Timothy Harrington; Jeffrey R Curtis; Daniel E Furst; Mary Jane Bentley; Ying Shan; George Reed; Joel Kremer; Jeffrey D Greenberg
Journal:  Arthritis Rheum       Date:  2012-03

4.  Monitoring performance for blood pressure management among patients with diabetes mellitus: too much of a good thing?

Authors:  Eve A Kerr; Michelle A Lucatorto; Rob Holleman; Mary M Hogan; Mandi L Klamerus; Timothy P Hofer
Journal:  Arch Intern Med       Date:  2012-06-25

5.  Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial.

Authors:  Amy G Huebschmann; Trina Mizrahi; Alyssa Soenksen; Brenda L Beaty; Thomas D Denberg
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-16       Impact factor: 3.738

6.  Symptom Care at Home: A Comprehensive and Pragmatic PRO System Approach to Improve Cancer Symptom Care.

Authors:  Kathi Mooney; Meagan S Whisenant; Susan L Beck
Journal:  Med Care       Date:  2019-05       Impact factor: 2.983

Review 7.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 8.  How can resistant hypertension be identified and prevented?

Authors:  Anna Solini; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2013-03-05       Impact factor: 32.419

9.  Part II, provider perspectives: should patients be activated to request evidence-based medicine? A qualitative study of the VA project to implement diuretics (VAPID).

Authors:  Colin D Buzza; Monica B Williams; Mark W Vander Weg; Alan J Christensen; Peter J Kaboli; Heather Schacht Reisinger
Journal:  Implement Sci       Date:  2010-03-18       Impact factor: 7.327

Review 10.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.